Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2022Pediatric DermatologyOpen Access

Reactive infectious mucocutaneous eruption following COVID‐19 in an adolescent boy: Case report and review of the literature

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAyisha MahamaThe University of Texas at AustinPKPriscilla Ly KojderNew York UniversityQTQuinn ThibodeauxUniversity of California, San Francisco

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mahama et al. (2022) studied this question.

synapsesocial.com/papers/6a5e2bbddec751667c70b2c2https://doi.org/10.1111/pde.15122
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reactive infectious mucocutaneous eruption secondary to SARS-CoV-22021 · 36 citations
  2. 2Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption2021 · 27 citations
  3. 3Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza A2021 · 36 citations
  4. 4Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three episodes2020 · 43 citations